Summary
In the present study insulin binding properties of human semi-synthetic and porcine insulin were compared in Type 1 (insulin-dependent) diabetic patients treated from the onset of their disease either with human semi-synthetic insulin (n=12) or porcine insulin (n=12) and control subjects (n=12). In all three groups, insulin binding to circulating monocytes revealed no difference between human semi-synthetic and porcine insulin (specific insulin binding at tracer concentration: 5.7±0.5% versus 5.4±0.5% in control subjects, 5.5 ± 0.4% versus 5.4±0.4% in Type1 diabetic patients on porcine insulin, 5.3±0.4% versus 5.6±0.4% in Type 1 diabetic patients on human insulin). Treatment with human or porcine insulin did not have any significant influence on receptor binding properties of the two diabetic groups investigated. Absolute receptor number and affinity of both diabetic groups were within the range of healthy control subjects irrespective of treatment with human or porcine insulin.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Schernthaner G, Borkenstein M, Fink M, Mayr WR, Menzel J, Schober E (1983) Immunogenicity of human insulin (Novo) or pork monocomponent insulin in HLA-DR-typed insulin-dependent diabetic individuals. Diabetes Care 6 (Suppl 1): 43–48
Home PD, Alberti KGMM (1982) Human insulin. Clin Endocrinol Metab 11: 453–483
Tager H, Given B, Baldwin D, Mako M, Markise J, Rubenstein A, Olefsky J, Kobayashi M, Koltermann O, Poncher R (1979) A structurally abnormal insulin causing human diabetes. Nature 281: 122–125
Bachmann W, Sieger C, Lacher F, Lotz N (1981) Binding of biosynthetic human insulin to erythrocytes of normal and insulin-dependent diabetic subjects. Comparison with pork and human pancreatic insulin. Diabetes Care 4: 215–219
Keefer LM, Piron MA, De Meyts P (1981) Human insulin prepared by recombinant DNA techniques an native human insulin interact identically with insulin receptors. Proc Nat Acad Sci 78: 1391–1395
WHO-Expert Committee on Diabetes Mellitus (1980) WHO Technical Report No 646, WHO, Geneva
Boyum A (1968) Separation of leukocytes from blood and bone marrow. Scand J Lab Clin Invest (Suppl. 97) 22: 77–89
Beck Nielsen H, Pedersen O, Kragballe K, Sörensen NS (1977) The monocyte as a model for the study of insulin receptors in men. Diabetologia 13: 563–569
Yam LT, Li CY, Crosby WN (1971) Cytochemical identification of monocytes and granulocytes. Am J Clin Path 55: 283–286
De Meyts P, Roth J (1975) Cooperativity in ligand binding: A new graphic analysis. Biochem Biophys Res Commun 66: 1118–1126
Welch SG, Boucher BJ (1978) A microscale method for the measurements of hemoglobin A/(a+b+C) Diabetologia 14: 209–211
Heding LG (1975) Radioimmunological determination of human C-peptide in serum. Diabetologia 11: 541–548
Fantus G, Ryan J, Gorden PH (1981) The insulin receptor in insulin-dependent diabetes mellitus: An in vivo and in vitro study. Metabolism 30: 510–517
Pedersen O, Beck Nielsen H, Heding L (1978) Insulin receptors on monocytes from patients with ketosis prone diabetes mellitus. Diabetes 27: 1098–1104
De Pirro R, Fusco A, Lauro R, Testa I, Ferreti G, Demartinis C (1980) Insulin receptors on monocytes and erythrocytes from obese patients. J Clin Endocrinol Metab 51: 1437–1439
Ward GM, Rees AR, Nylor BA, Turner RC (1981) The relationship of erythrocyte insulin receptors to the cell age and to monocyte insulin receptors. Clin Endocrin 14: 269–278
Prager R, Schernthaner G (1982) Comparison of insulin receptor binding of monocytes and erythrocytes in type II diabetes mellitus. Horm Metab Res 14: 561–563
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Prager, R., Schernthaner, G. Insulin binding of human and porcine monocomponent insulin to monocytes in Type 1 (insulin-dependent) diabetic patients and control subjects. Diabetologia 25, 235–237 (1983). https://doi.org/10.1007/BF00279935
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00279935